Scientus Pharma

What Scientus Pharma does

Scientus Pharma is a Canadian privately-held pharmaceutical company founded in 2013 and headquartered in Whitby, Ontario. The company's stated mission is to develop and commercialize pharmaceutical-grade cannabis derivative products, positioning it at the intersection of the regulated cannabis and drug development sectors in Canada.

The company is co-founded by Har Grover and Rav Grover and operates with a headcount of 11-50 employees, indicating an early-to-mid stage clinical-stage or pre-commercial scale consistent with pharmaceutical development timelines. A single funding round from CannaIncome Fund was recorded in January 2019, with no subsequent capital raises disclosed in the available data. No products, pipeline assets, clinical milestones, manufacturing capabilities, regulatory filings, or commercial partnerships are documented in the input.

A notable anomaly is that the company's primary web domain, scientuspharma.com, currently serves content for OLXTOTO, an Indonesia-facing online lottery and slot gambling platform, with no apparent connection to the pharmaceutical cannabis business. The corporate relationship between Scientus Pharma and OLXTOTO is not explained in the available data, and the domain's current state raises material questions about operational continuity, data integrity, or an undisclosed strategic shift that investors would need to diligence directly with the company.

Name

Scientus Pharma

Legal name

OLXTOTO

Website

https://scientuspharma.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

Scientus Pharma is a privately-held Canadian pharmaceutical company, founded in 2013 and based in Whitby, Ontario, developing pharmaceutical-grade cannabis derivative products. The company is co-founded by Har Grover and Rav Grover and operates at an early-stage clinical scale of 11-50 employees.

Ownership category

akta.pro rank

Headquarters

HQ city

Whitby

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Gaming Transactions: Platform takes a cut from player bets and transactions on lottery (togel) and slot games. Offers betting discounts up to 70% to attract players.
2. Platform Services: 24/7 customer support and transaction processing services bundled with platform access

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Scientus Pharma develops and commercializes pharmaceutical-grade cannabis derivative products intended for therapeutic use. The company focuses on transforming cannabis into standardized, pharmaceutical-quality formulations aligned with regulated medical and healthcare markets in Canada.

Product overview

OLXTOTO is an online gambling platform providing lottery (Togel) and slot gaming services. The platform aggregates games from multiple third-party providers (Pragmatic Play, PG Soft, Habanero, Joker Gaming) and offers official lottery markets including Singapore, Hongkong, and Sydney with betting discounts up to 70%.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical-grade cannabis derivative products Standardized cannabis derivative products manufactured to pharmaceutical-grade specifications for use in regulated medical cannabis and healthcare channels in Canada.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Pragmatic PlaycoreTechnology or IntegrationGame provider integrated into OLXTOTO platform, supplying slot games to the platform's gaming portfolio.
• PG SoftcoreTechnology or IntegrationGame provider supplying mobile-optimized slot games to the platform.

Scale indicators2 records

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Canopy Growth Corporation: Canopy Growth is a major Canadian cannabis company with defined medical and cannabinoid pharmaceutical lines. Comparable as a Canadian licensed cannabis producer pursuing standardized medical/pharmaceutical products, though its portfolio is far broader than Scientus's focused derivatives play.
• Aurora Cannabis: Aurora Cannabis is a Canadian licensed producer with medical cannabis and EU GMP-certified manufacturing. Comparable as a Canada-based cannabis operator investing in pharmaceutical-grade production and global medical distribution, but at much larger scale.
• Cronos Group: Cronos Group is a Canadian licensed cannabis producer with a medical product line and cannabinoid research initiatives. Comparable as a Canadian cannabis operator with medical/pharma ambitions, though its portfolio also includes large-scale recreational brands.
• Tilray Brands: Tilray is a large Canadian cannabis producer with a pharmaceutical and medical cannabis division. Comparable as a Canadian cannabis operator pursuing pharmaceutical-grade products and international medical distribution, but at vastly greater scale than Scientus Pharma.

Direct peers

• The Valens Company: Valens is a Canadian cannabis extraction and derivative product manufacturer serving medical, recreational, and pharma-adjacent channels. Comparable as a Canadian peer focused on cannabis derivative manufacturing and white-label/contract services rather than retail cultivation.
• MediPharm Labs: MediPharm Labs is a Canadian cannabis extraction specialist producing pharmaceutical-grade cannabis derivatives and APIs for B2B partners. Directly comparable as a smaller Canadian-focused cannabis derivative and API manufacturer serving medical and pharmaceutical buyers.
• Emerald Health Therapeutics: Emerald Health Therapeutics is a Canada-based cannabis company pursuing pharmaceutical-grade and medical cannabis products. Comparable as a smaller Canadian peer developing cannabinoid-based pharmaceutical and wellness products for regulated medical channels.
• OrganiGram Holdings: OrganiGram is a Canadian licensed cannabis producer with a focus on medical and pharmaceutical-grade products and international distribution. Closely comparable as a Canada-headquartered cannabis company targeting medical and pharma channels with similar customer types.

Regional players

• Hexo Corp: Hexo Corp is a Canadian cannabis producer with medical and derivative product offerings. Comparable in Canadian cannabis manufacturing and medical channel focus, though it has since been acquired and now operates within a larger US-focused group.
• Pharmacielo Ltd. Pharmacielo is a cannabis and cannabinoid pharmaceutical company focused on medical-grade cannabis derivative APIs. Comparable in the cannabis pharma manufacturing and API space, though primarily Colombia-based rather than Canadian.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/ScientusPharma
• Facebookfacebook.com/ScientusPharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scientus Pharma